Doctor profile · Federal record
Dr. ANDREW BAYAT, M.D.
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · Student in an Organized Health Care Education/Training Program · DALLAS, TX
- NPI 1316380058
- Accepts Medicare
- 13 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
221 W COLORADO BLVD STE 525
DALLAS, TX 752082312
(214) 960-5681 - Additional location
-
5201 Harry Hines Blvd, Graduate Medical Education
Dallas, TX 752357708
(214) 590-8058 - Mailing address
-
PO BOX 660599
DALLAS, TX 752660599
Credentials & registration
- NPI registered
- April 2013 — 13 yrs on file
- Profile last updated
- July 10, 2019
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Texas #Q8428
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316380058. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
584
Distinct HCPCS
7
Medicare allowed
$96,951
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 324 | 155 | $208 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 157 | 98 | $117 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 27 | 13 | $78 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 25 | 24 | $170 | |
36556 |
Insertion of non-tunneled central venous tube for infusion (5 years or older) | 24 | 18 | $81 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 14 | 14 | $90 | |
31500 |
Emergent insertion of breathing tube into windpipe using an endoscope | 13 | 13 | $136 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 88. This provider delivers 6.6× the peer median.Open Payments
Industry payments received
All-time total
$45
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 1 | $23.72 | |
| Abbott Laboratories | 1 | $21.68 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
59
Patients
11
Total drug cost
$24,849
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 25 | 11 | $554 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 19 | 0 | $18,455 |
| Wixela Inhub (Fluticasone Propion/Salmeterol) | Brand | 15 | 0 | $5,840 |